ArticleScientific reports2025
Clinical, histological, and immunohistochemical signatures of non-segmental vitiligo: A case-control analysis of Melan-A expression and CD8⁺ T-cell infiltration.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Pathogenesis of Vitiligo: Integrating Immune and Non-Immune Cell Crosstalk.The Journal of dermatology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors.
Funding
Abstract
Non-segmental vitiligo (NSV) is a chronic autoimmune skin disease marked by melanocyte loss and depigmented macules. While clinical features are well recognized, immunohistological correlates such as Melan-A expression and CD8⁺ T-cell infiltration remain undercharacterized. To examine the clinical, histological, and immunohistochemical features of NSV, with a focus on their relationship to disease severity. In this prospective case-control study, 25 NSV patients and 25 matched healthy controls were evaluated using standardized scoring systems (VASI, VIDA, VETF, VETI). Biopsies from lesional, marginal, and normal skin underwent immunohistochemical staining for Melan-A and CD8⁺ T cells. Histopathological changes were graded using a structured scoring system. Lesional skin exhibited significant melanocyte loss (Melan-A⁺ median: 5 [IQR: 3-8]) and elevated CD8⁺ T-cell infiltration (median: 15 [10-18]) compared to controls (p < 0.001). Marginal zones showed intermediate values, indicating subclinical immune activation. CD8⁺ infiltration positively correlated with VASI (r = 0.53), while Melan-A expression showed a negative correlation (r = - 0.55). Both markers were independent predictors of disease severity. NSV exhibits a spatial immunohistological gradient, where melanocyte loss and CD8⁺ T-cell infiltration parallel clinical severity. The integration of immunophenotyping with clinical scoring provides a novel biomarker strategy for personalized therapy.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.